Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Wanlong Pharmaceutical is a comprehensive pharmaceutical enterprise located in Shijiazhuang, China, dedicated to the research, development, production, and sales of chemical drugs. The company's product portfolio primarily targets cardiovascular and cerebrovascular diseases, respiratory conditions, and infectious diseases. It operates modern manufacturing facilities that comply with national GMP standards, producing various formulations including solid orals and sterile injections. Hebei Wanlong Pharmaceutical emphasizes technological innovation and quality control to maintain its competitive position in the Chinese generic drug market. The company is recognized as a High-tech Enterprise in Hebei Province and continues to expand its reach within the domestic healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Wanlong Pharmaceutical.